Suppr超能文献

口咽和口腔持续性癌经后装组织间192铱植入再治疗。

Persistent carcinoma of the oropharynx and oral cavity re-treated by after-loading interstitial 192Ir implant.

作者信息

Syed A M, Feder B H, George F W

出版信息

Cancer. 1977 Jun;39(6):2443-50. doi: 10.1002/1097-0142(197706)39:6<2443::aid-cncr2820390622>3.0.co;2-5.

Abstract

After-loading implantation techniques apparently offer an effective alternative in the management of persistent (or recurrent) oropharynx and oral cavity carcinoma postirradiation. A total of 29 patients with such lesions was treated from February 1974, to July 1975, in the LAC/USC Radiation Medicine Section, using after-loading 192Ir implantation techniques. These patients all had extensive persistent cancer after "full tolerance" irradiation (with or without previous surgery) and were referred for palliation or for possible salvage. Additional doses administered ranged from 5000 to 7000 rads in three to five days. Eighteen of the 29 patients (63%) have had complete local control for 18 to 36 months. These patients have maintained a relatively satisfactory palliative status. Ten of the 29 are dead. Follow-up periods are short, but early indications are that problem patients with persistent cancer after "full tolerance irradiation" can be salvaged, or at least satisfactorily palliated, with after-loading interstitial implant techniques. Clinical details, sites of involvement, implantation techniques, dosimetry methodology, reactions and complications will be described.

摘要

后装植入技术显然为放疗后持续性(或复发性)口咽癌和口腔癌的治疗提供了一种有效的替代方法。1974年2月至1975年7月期间,洛杉矶儿童医院/南加州大学放射医学科使用后装192铱植入技术对29例患有此类病变的患者进行了治疗。这些患者在接受“全耐受量”放疗(无论是否曾接受过手术)后均患有广泛的持续性癌症,被转诊来接受姑息治疗或可能的挽救性治疗。在三到五天内给予的额外剂量范围为5000至7000拉德。29例患者中有18例(63%)实现了18至36个月的局部完全控制。这些患者维持了相对满意的姑息状态。29例中有10例死亡。随访期较短,但早期迹象表明,采用后装组织间植入技术,“全耐受量放疗”后患有持续性癌症的问题患者可以得到挽救,或至少得到满意的姑息治疗。将描述临床细节、受累部位、植入技术、剂量测定方法、反应和并发症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验